España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
DiaMedica Therapeutics
DMAC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.70
0.52
12.44%
At close: -
$4.00
-0.7
-14.89%
After Hours: Nov 21, 9:14 AM EDT
Get Report
Comment
DiaMedica Therapeutics (DMAC) Forecast
News
Earnings
DiaMedica Therapeutics (DMAC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for DiaMedica Therapeutics (NASDAQ:DMAC) Stock
DiaMedica Therapeutics Stock (NASDAQ: DMAC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on DiaMedi...
Benzinga Newsdesk
Wednesday, November 13, 2024
DiaMedica Therapeutics Q3 2024 GAAP EPS $(0.1...
Benzinga Newsdesk
DiaMedica Therapeutics Doses First Patient In...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
Preview: DiaMedica Therapeutics's Earnings
Benzinga Insights
Thursday, October 10, 2024
HC Wainwright & Co. Reiterates Buy on DiaMedi...
Benzinga Newsdesk
Wednesday, October 09, 2024
DiaMedica Therapeutics Receives Regulatory Ap...
Benzinga Newsdesk
Monday, October 07, 2024
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor
HC Wainwright & Co. Initiates Coverage On Dia...
Benzinga Newsdesk
Friday, August 16, 2024
Oppenheimer Reiterates Outperform on DiaMedic...
Benzinga Newsdesk
Wednesday, August 07, 2024
DiaMedica Reiterates Its Guidance That Full E...
Benzinga Newsdesk
DiaMedica Therapeutics Q2 2024 GAAP EPS $(0.1...
Benzinga Newsdesk
Thursday, July 11, 2024
DiaMedica Therapeutics Releases Preeclampsia ...
Benzinga Newsdesk
Wednesday, July 10, 2024
DiaMedica Therapeutics Files For Resale Of Up...
Benzinga Newsdesk
Wednesday, June 26, 2024
DiaMedica Therapeutics shares are trading hig...
Benzinga Newsdesk
DiaMedica Therapeutics Announces $11.8M Priva...
Benzinga Newsdesk
DiaMedica Therapeutics Announces Expansion Of...
Benzinga Newsdesk
Wednesday, May 08, 2024
DiaMedica Therapeutics Q1 2024 GAAP EPS $(0.1...
Benzinga Newsdesk
Wednesday, April 24, 2024
Craig-Hallum Assumes DiaMedica Therapeutics a...
Benzinga Newsdesk
Wednesday, April 17, 2024
DiaMedica Therapeutics Doses First Patient Re...
Benzinga Newsdesk
Thursday, March 21, 2024
Craig-Hallum Maintains Buy on DiaMedica Thera...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on DiaMedic...
Benzinga Newsdesk
Tuesday, March 19, 2024
Recap: DiaMedica Therapeutics Q4 Earnings
Benzinga Insights
DiaMedica Therapeutics FY23 EPS $(0.60) Vs $(...
Benzinga Newsdesk
Monday, November 13, 2023
DiaMedica Therapeutics Q3 EPS $(0.12) Beats $...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights
Friday, November 10, 2023
Earnings Outlook For DiaMedica Therapeutics
Benzinga Insights
Monday, August 14, 2023
DiaMedica Therapeutics Q2 EPS $(0.16) Beats $...
Benzinga Newsdesk
Earnings Scheduled For August 14, 2023
Benzinga Insights
Thursday, June 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023
Benzinga Insights
Oppenheimer Upgrades DiaMedica Therapeutics t...
Benzinga Newsdesk
Wednesday, June 21, 2023
DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199
Nabaparna Bhattacharya
DiaMedica Therapeutics Announces $37.5M Private Placement Of 11,011,406 Common Shares At A Purchase Price Of $3.40/Share
Happy Mohamed
DiaMedica Therapeutics Announces That The FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
Happy Mohamed
Monday, May 22, 2023
Diamedica Therapeutics Included In Response T...
Benzinga Newsdesk
Filed On May 19, DiaMedica Therapeutics A Com...
Benzinga Newsdesk
Monday, May 15, 2023
DiaMedica Therapeutics Q1 EPS $(0.20) Misses ...
Benzinga Newsdesk
Earnings Scheduled For May 15, 2023
Benzinga Insights
Friday, May 12, 2023
Earnings Preview: DiaMedica Therapeutics
Benzinga Insights
Tuesday, March 28, 2023
DiaMedica Therapeutics FY22 EPS $(0.52)
Michael Horton
DiaMedica Therapeutics Provides A Business Update And Announces FY22 Financial Results; DiaMedica Reported Total Cash, Cash Equivalents And Investments Of $33.5M
Happy Mohamed
Earnings Scheduled For March 28, 2023
Benzinga Insights
Monday, March 27, 2023
DiaMedica Therapeutics's Earnings Outlook
Benzinga Insights
Friday, December 02, 2022
$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying
Lisa Levin
Wednesday, November 09, 2022
DiaMedica Therapeutics Q3 EPS $(0.12) Up From...
Benzinga Newsdesk
Monday, November 07, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, October 28, 2022
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
Lisa Levin
Friday, October 07, 2022
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Lisa Levin
Thursday, October 06, 2022
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Thursday, August 11, 2022
DiaMedica Therapeutics: Q2 Earnings Insights
Benzinga Insights
Show More